Clinical outcomes of female breast cancer according to BRCA mutation status

Conclusions BRCAm carriers may have a better prognosis than BRCAwt women. However, limited testing conducted mainly during follow-up, yielded low numbers for precise estimations, and may be attributable to selection bias.
Source: Cancer Epidemiology - Category: Cancer & Oncology Source Type: research